Trump Admin Pushes for Quick Supreme Court Tariff Decision

Summary

---

WSJ What’s News – AM Edition

Episode: Trump Admin Pushes for Quick Supreme Court Tariff Decision
Host: Azhar Sukri
Date: September 4, 2025

---

Episode Overview

This episode covers several breaking stories impacting business, finance, and politics in the U.S. and globally. Major topics include the Trump administration’s push for an expedited Supreme Court ruling on tariffs, court decisions affecting Harvard’s research funding, proposed changes to the CDC led by Health Secretary Robert F. Kennedy Jr., and Republican efforts to challenge corporate climate action initiatives.

---

Key Discussion Points & Insights

1. Trump Administration’s Push for Quick Supreme Court Tariff Decision

• Background: The administration is appealing a ruling that found the president exceeded authority by imposing global trade tariffs under emergency powers.
• What’s at Stake: Up to $1 trillion in potential tariff revenues could be held up or unwound if legal uncertainty continues.
• Immediate Impact: Trade talks with other countries are stalling due to the “legal limbo” (01:54).
• Quote:
  • “Other countries are holding off on striking deals because they’re not yet sure about the status of these tariffs.”
    — Quentin Webb, Deputy Finance Editor, (01:54)
• Small Business Concerns: The plaintiffs—small businesses—also favor a quick resolution due to harm from the tariffs.
• Legal Question: Whether the International Emergency Economic Powers Act of 1977 gives the president authority to impose tariffs, or if those are constitutionally considered taxes outside the law’s remit (02:54).
• Market Reactions: The potential loss of tariff revenue unsettled bond markets, which saw a sell-off after the court ruling, highlighting concerns over U.S. fiscal sustainability (03:34).

2. Federal Judge Restores Harvard's Research Funding

• Ruling: A U.S. District Judge found that the Trump administration’s $2.2 billion funding cut violated Harvard’s constitutional rights and was “a targeted, ideologically motivated assault” (04:18).
• Impact on Research:
  • “I've been wanting to create custom stem cell therapies for heart disease, and obviously that needs funding, that needs support. ... This funding not being cut is funding that can come towards my project, come towards my goals.”
    — Sia Patel, Harvard Medical School student, (05:03)
• Next Steps: The Trump administration plans to appeal; future federal funding for Harvard remains uncertain.

3. White House Seeks Greater Control over the Federal Reserve

• Nomination: The Senate is considering confirming Stephen Myron, a senior White House economic adviser, to the Fed’s Board of Governors.
• Implications: This could challenge longstanding norms about Fed independence, with the President attempting to directly influence monetary policy.

4. Health Secretary RFK Jr.’s Radical CDC Overhaul

• Restructuring Plans: Kennedy aims to refocus the CDC exclusively on infectious diseases and transfer other programs (chronic disease, environmental health, HIV, etc.) to a new agency.
• Internal Fallout: Over 1,000 current/former HHS employees have called for Kennedy’s resignation; three top CDC officials—including Chief Medical Officer Dr. Deborah Howrey—have resigned, citing risks to public health (07:17).
• Quote:
  • “The reorganization plans would remove the Chronic Disease center, the Injury center, some of our environmental health work, birth defects … Not having those at CDC means that when we have an overdose in communities, we're not going to be able to respond to them.”
    — CDC Official, (07:17)
• Congressional Oversight: Kennedy is expected to face Senate scrutiny, particularly concerning agency turmoil and resignations.

5. GOP Attorneys General Challenge Corporate Climate Action

• New Front: 23 Republican AGs—led by Iowa’s Brenner Byrd—are investigating groups like the Science Based Targets Initiative (SBTi), alleging anti-competitive behavior and that net zero standards harm state industries (08:44).
• Role of SBTi & CDP:
  • “They basically help companies to report on their climate emissions, validate their transition plans to try and get to net zero.”
    — Yousef Khan, Sustainability Reporter, (09:58)
• Legal Strategies: Moving from Congressional actions to state AG lawsuits, targeting both asset managers and sustainability reporting bodies (10:38).
• Debate Over Red Tape: While climate initiatives add costs (mainly for accounting and strategy), supporters argue that more disclosure helps investors make informed decisions (11:26).

---

Notable Quotes & Memorable Moments

• On Tariff Uncertainty:
  • “If a ruling is delayed until June 2026 ... that could result in up to $1 trillion in tariffs which have already been collected, potentially being unwound.”
    — Quentin Webb (01:54)
• On Harvard Funding:
  • “A lot of that money is being used for life saving research ... it’s not like the advances that are being made from Harvard are insular. They're to help the general public.”
    — Harvard Research Advocate (00:41)
• On Public Health Risks:
  • “Not having those at CDC means that when we have an overdose in communities, we're not going to be able to respond to them.”
    — CDC Official (07:17)
• On Corporate Climate Reporting:
  • “Investors want more disclosure. The more information investors have, the more they can make decisions based on where they actually want to put their money.”
    — Yousef Khan (11:26)

---

Important Timestamps

• 00:18 — Episode headlines and rundown
• 00:53 — Overview of Trump administration’s Supreme Court appeal on tariffs
• 01:54 — Quentin Webb on urgency and market impact of tariff litigation
• 02:54 — Legal details on the Supreme Court’s review of tariff authority
• 03:34 — Market and investor reactions to court rulings
• 04:18 — Federal judge restores Harvard’s funding
• 05:03 — Harvard medical student on the importance of research funding
• 07:17 — CDC official on ramifications of proposed agency restructuring
• 08:44 — GOP AGs move against climate initiatives; reporter discussion
• 09:58 — What SBTi and CDP do for corporate climate action
• 10:38 — Legal strategies Republican AGs are using
• 11:26 — Costs and benefits debate over climate disclosure requirements

---

This episode provided in-depth analysis of pivotal legal, financial, and political confrontations shaping U.S. policy and global markets, balancing rapid news delivery with high-level insight from WSJ reporters and experts.

Transcript

[Podcast Host]

Exchanges on navigating macro uncertainty exchanges on the forces shaping global markets. For the sharpest analysis on finance, business and the economy count on exchanges. The Goldman Sachs podcast listen now.

[Azhar Sukri]

The Trump administration calls for a quick Supreme Court decision on tariffs, saying trade talks are already being impacted. Plus, RFK Jr faces fresh Senate scrutiny as he pushes to radically remake the CDC and relief for Harvard. As a judge rules the Trump administration's funding cuts are unconstitutional.

[Harvard Research Advocate]

A lot of that money is being used for life saving research to advance research in Alzheimer's cancer. It's being put to good causes. And it's not like the advances that are being made from Harvard are insular. They're to help the general public.

[Azhar Sukri]

Its Thursday, September 4th. I'm Azhar Sukri for the Wall Street Journal. Here is the AM Edition of what's news, the top headlines and business stories moving your world today. With up to $1 trillion in potential tariff revenues at stake, the Trump administration is trying to speed through its Supreme Court appeal of an earlier legal ruling that rejected the president's global trade levies. US Solicitor General John Sa urged the justices yesterday to grant review and expedite the case. He cited the, quote, enormous importance of quickly confirming the full legal standing of the president's tariffs. A federal appeals court ruled last week that Trump had exceeded his authority by claiming emergency authority to rewrite US Trade policy. Deputy finance editor Quentin Webb joins me now. Quentin, explain to us why the administration is in such a hurry.

[Quentin Webb]

So the administration argues that the legal limbo it is in at the moment over tariffs is already adversely affecting negotiations with other countries because effectively other countries are holding off on striking deals because they're not yet sure about the status of these tariffs. And the filing from the US Government cites Treasury Secretary Scott Bethen as saying if a ruling is delayed until June 2026, which is the end of the court's next term, that could result in up to $1 trillion in tariffs which have already been collected, potentially being unwound. On the other side of the case, the small businesses that brought this to the trade court in the first place are also keen to see this resolved quickly. You know, they say that these tariffs are causing serious harm to small businesses and in some cases putting their very survival at risk. And so they would like to see this adjudicated on quickly.

[Azhar Sukri]

Just taking a step back here, Quentin, what exactly is the Supreme Court looking at?

[Quentin Webb]

Two courts now have found that President Trump's use of a 1977 law, the International Emergency Economic Powers act, to impose tariffs is unjustified effectively, the courts have found that the tariffs and taxes, and that is not something that is covered by the remit of that act, which instead is centred more on the ability to regulate trade rather than to impose taxes. That's the core question that is at stake and will be considered by the Supreme Court.

[Azhar Sukri]

Now, with so much money at stake, of course, this is going to be keenly watched by the markets. How have investors responded?

[Quentin Webb]

That's right. So there's a lot of concern in the markets in general about budget deficits and the health of the US Government finances. And so tariff revenue is seen as one important way of plugging some of those holes. And in fact, at the beginning of the week, when we had this court ruling upholding the earlier judgment that the tariffs weren't on strong legal grounds, we did see a bit of a sell off in the bond markets, which some participants attributed partly to this, emphasizing how much this plays into wider discussions about government fiscal sustainability.

[Azhar Sukri]

Deputy Finance Editor Quentin Webb, thanks so much for joining me today.

[Quentin Webb]

Thanks a.

[Azhar Sukri]

Lot. A federal judge has ruled that the Trump administration improperly cut off $2.2 billion in research funding from Harvard University and must restore the fund. Yesterday's ruling by U.S. district Judge Alison Burroughs of Massachusetts concluded that the federal administration's actions violated Harvard's constitutional rights and that the government used antisemitism as a smokescreen for, quote, a a targeted, ideologically motivated assault on this country's premier universities. Harvard cheered its victory. However, the cuts to funding have already had an impact on important research. One of those affected is Harvard Medical School student Sia Patel.

[Sia Patel]

I've been wanting to create custom stem cell therapies for heart disease, and obviously that needs funding, that needs support. So specifically for me, this funding not being cut is funding that can come towards my project, come towards my goals, and hopefully in the future, this is a goal that can become realized and enter the market.

[Azhar Sukri]

The judge ordered the federal government not to cut off any additional funds to Harvard. However, the university's ability to get money from the administration in the future remains a question mark. The Trump administration vowed to appeal the court ruling. President Trump's bid to bring the Federal Reserve under closer White House control faces a major test today. Senate will discuss confirming senior White House economic adviser Stephen Myron to the central bank's Board of Governors. The president has attempted to fire one Fed governor and publicly berated the central bank for not lowering rates. The Senate Banking Committee hearing will, for the first time force GOP senators to balance their past support for Fed independence against their reluctance to cross Trump. At a Cabinet meeting last week, the president highlighted his desire to more directly influence interest rate policy, including with Myron's confirmation and Health Secretary Robert F. Kennedy Jr. Is moving to radically remake the Centres for Disease Control and Prevention, despite more than 1,000 current and former Health and Human Services employees calling on him to resign. In op eds and interviews this week, Kennedy said the CDC had squandered public trust and suggested further changes to its workforce were necessary, including shifting the agency to focus on infectious diseases, moving chronic disease work to his Administration for a Healthy America. In response, CDC employees anticipate more resignations, while others say they are determined to stay out of concern that a mass exodus would further strip the country's leading health agency of its institutional expertise. Three top CDC officials, including the agency's Chief Medical Officer, Dr. Deborah Howrey, resigned last week, saying that Kennedy is putting America's health at risk.

[CDC Official]

The reorganization plans would remove the Chronic Disease center, the Injury center, some of our environmental health work, birth defects, our occupational health work and the HIV program. Not having those at CDC means that when we have an overdose in communities, we're not going to be able to respond to them. If there's a suicide cluster, we're not going to be able to detect it, we're not going to be able to test for new fentanyl analogs and we're not going to be able to prevent HIV and do some of that cutting edge testing we have been doing.

[Azhar Sukri]

To me, that's concerning Lawmakers have raised concerns about the turmoil at the cdc, with Kennedy expected to face scrutiny from the Senate Finance Committee during a hearing later this morning. Coming up, how corporate climate action is being hampered by Republican lawyers across the U.S. we look at the impact of these efforts after the break.

[Podcast Host]

So you're about to make a trade based on a friend's text, but which u do you listen to is it we could buy a house in Tulum get optioning those options, we could lose everything. Or let's do a little research, get your head in the trade and make the investment decision that's right for you. Learn [e-mail] TradeSmart Foreign.

[Azhar Sukri]

The Republicans push back against Climate Regulations is entering a new front GOP attorneys general across the US Are looking to stymie corporate climate action, setting up investigations into a number of key reporting and target setting groups. Earlier this month, 23 AGs led by Iowa's Brenner Byrd wrote a letter to a British charity, the Science Based Targets Initiative, that validates climate goals for companies. The world over. In it, she argues that the SBTI is engaging in anti competitive behavior that is hurting American businesses and consumers in their states. In an email to WSJ pro, the Iowa AG's office said that we are keeping our eyes open to ensure no organisation imposes net zero standards that are used to raise costs for Iowans and hurt agriculture. The SBTI declined to comment. Journals Sustained Sustainability reporter Yousef Khan has been following the Republicans efforts. Yousef firstly explain the role that the Science Based Targets initiative and other similar organisations play in trying to reduce greenhouse gas emissions.

[Yousef Khan]

So the SBTI and CDP and organisations like that, they're some of the most important organisations within the world of sustainability in terms of the sbti. They basically help companies to report on their climate emissions, validate their transition plans to try and get to net zero and also sort of structure how you can sort of go about doing that. You know, that might be getting more green electricity for your factories or things like that. CDP is more of a reporting initiative and it's more about climate disclosure and sort of figuring out, you know, where your emissions come from and how you could get those down in theory.

[Azhar Sukri]

So what strategies are Republicans using to unwind climate initiatives?

[Yousef Khan]

So in the past, especially in the past year, what we saw a lot of was a lot of more movements in the House and House Republicans, you know, bringing motions against climate organizations. Now what we're seeing more is this movement within attorney generals, so within state courthouses. We saw it in the winter with Texas and their movements against BlackRock. The lawsuit basically said that asset managers like BlackRock were trying to stymie coal investment, something that is a big contributor to greenhouse gas emissions. But they said you know that's uncompetitive and that you are limiting investors diversity of energy supply. And now we're seeing that again here but with reporting initiatives, something that thousands of US companies are a part of.

[Azhar Sukri]

Do they have a point that a lot of this red tape has really curtailed industry and growth in terms of.

[Yousef Khan]

Growth, most of the nonprofits that support groups like the sbti, they say that investors want more disclosure. The more information investors have, the more they can make decisions based on where they actually want to put their money. You see that a lot more with pension funds and insurance companies because of the long term investment horizons. So that's what its proponents say in terms of red tape or in terms of bureaucracy. They do add to costs for companies but mainly you've seen in accounting costs and then how strategy changes and that could be within a wider strategy as any company takes.

[Azhar Sukri]

Journal sustainability reporter Yousef Khan. Thank you so much.

[Yousef Khan]

Thank you.

[Azhar Sukri]

And that's it for what's news for this Thursday morning. Today's show was produced by Kate Bullivant and Daniel Bar. Our supervising producer is Sandra Kilhoff. I'm Azhar Sukri for the Wall Street Journal. We'll be back tonight with a new show.

[Yousef Khan]

Until then, thanks for listening.